Featured in R2GConnect: A new era in GLP-1 obesity management
- Stijn Zwaagstra
- Apr 2
- 2 min read
The healthcare landscape is evolving rapidly, and at EW2Health, we are leading the way in adapting to these changes. We were honored to be featured in an exclusive interview with R2GConnect, where our founder, Renato Romani, shared how we have redefined our approach to obesity care in response to the rise of GLP-1 therapies.
The GLP-1 Revolution: A New Era in Obesity Management
GLP-1 medications like Ozempic and Wegovy have reshaped weight management, offering patients significant weight loss potential. However, medication alone is not a comprehensive solution. Many health providers face challenges in managing patient expectations, addressing side effects, and ensuring long-term adherence. This is where EW2Health comes in—with a tailored digital solution designed to enhance the effectiveness of GLP-1 treatments.
Our Evolution: From Behavioral Change to GLP-1 Companion
Originally, EW2Health focused on stress-free weight monitoring through our Predictive Behavioral Algorithm (PBA), which helped users track weight trends without daily weigh-ins. As GLP-1 therapies gained traction, we saw an opportunity to fill a critical gap—helping clinics monitor patient progress more effectively.
By transitioning to a B2B SaaS model, we now offer clinics an advanced real-time monitoring dashboard that integrates seamlessly with wearables and pharmacy systems. Our AI-driven insights enable clinics to optimize patient retention, improve medication adherence, and drive better long-term outcomes. We are already working with leading GLP-1 clinics in the Netherlands and are expanding into Brazil with large-scale pilot programs.
The Future of Personalized Digital Health
At EW2Health, adaptability is our strength. By embracing the GLP-1 revolution, we are helping health providers scale personalized obesity care with predictive analytics and seamless monitoring. As digital health continues to evolve, we are committed to leading the way in innovative, patient-centered solutions.
A big thank you to R2GConnect and Ralf-Gordon Jahns for the opportunity to share our journey!